These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 22926003

  • 21. MPG-based nanoparticle: An efficient delivery system for enhancing the potency of DNA vaccine expressing HPV16E7.
    Saleh T, Bolhassani A, Shojaosadati SA, Aghasadeghi MR.
    Vaccine; 2015 Jun 22; 33(28):3164-70. PubMed ID: 26001433
    [Abstract] [Full Text] [Related]

  • 22. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S, Mohebbi A, Vakilzadeh G, Biglari P, Razeghi Jahromi S, Mohebi SR, Shirian S, Gorji A, Ghaemi A.
    Arch Virol; 2018 Mar 22; 163(3):587-597. PubMed ID: 29149434
    [Abstract] [Full Text] [Related]

  • 23. Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects.
    Chen CA, Chang MC, Sun WZ, Chen YL, Chiang YC, Hsieh CY, Chen SM, Hsiao PN, Cheng WF.
    Gene Ther; 2009 Jun 22; 16(6):776-87. PubMed ID: 19357714
    [Abstract] [Full Text] [Related]

  • 24. Gene gun-mediated DNA vaccination induces antitumor immunity against human papillomavirus type 16 E7-expressing murine tumor metastases in the liver and lungs.
    Chen CH, Ji H, Suh KW, Choti MA, Pardoll DM, Wu TC.
    Gene Ther; 1999 Dec 22; 6(12):1972-81. PubMed ID: 10637448
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A novel recombinant protein vaccine containing the different E7 proteins of the HPV16, 18, 6, 11 E7 linked to the HIV-1 Tat (47-57) improve cytotoxic immune responses.
    Mousavi T, Valadan R, Rafiei A, Abbasi A, Haghshenas MR.
    Biotechnol Lett; 2021 Sep 22; 43(9):1933-1944. PubMed ID: 34313864
    [Abstract] [Full Text] [Related]

  • 28. Influence of the route of immunization and the nature of the bacterial vector on immunogenicity of mucosal vaccines based on lactic acid bacteria.
    Cortes-Perez NG, Lefèvre F, Corthier G, Adel-Patient K, Langella P, Bermúdez-Humarán LG.
    Vaccine; 2007 Sep 04; 25(36):6581-8. PubMed ID: 17675182
    [Abstract] [Full Text] [Related]

  • 29. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
    Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct 04; 29(5):584-91. PubMed ID: 18051710
    [Abstract] [Full Text] [Related]

  • 30. A novel fusion protein-based vaccine comprising a cell penetrating and immunostimulatory peptide linked to human papillomavirus (HPV) type 16 E7 antigen generates potent immunologic and anti-tumor responses in mice.
    Granadillo M, Vallespi MG, Batte A, Mendoza O, Soria Y, Lugo VM, Torrens I.
    Vaccine; 2011 Jan 29; 29(5):920-30. PubMed ID: 21145912
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.
    Lin CT, Tsai YC, He L, Yeh CN, Chang TC, Soong YK, Monie A, Hung CF, Lai CH.
    Immunol Lett; 2007 Dec 15; 114(2):86-93. PubMed ID: 17976741
    [Abstract] [Full Text] [Related]

  • 34. Therapeutic human papillomavirus DNA vaccination strategies to control cervical cancer.
    Wu TC.
    Eur J Immunol; 2007 Feb 15; 37(2):310-4. PubMed ID: 17273998
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Strong immune responses induced by a DNA vaccine containing HPV16 truncated E7 C-terminal linked to HSP70 gene.
    Meshkat Z, Soleimanjahi H, Mirshahabi H, Meshkat M, Kheirandish M, Hassan ZM.
    Iran J Immunol; 2011 Jun 15; 8(2):65-75. PubMed ID: 21705833
    [Abstract] [Full Text] [Related]

  • 37. A non-pathogenic live vector as an efficient delivery system in vaccine design for the prevention of HPV16 E7-overexpressing cancers.
    Hosseinzadeh S, Bolhassani A, Rafati S, Taheri T, Zahedifard F, Daemi A, Taslimi Y, Hashemi M, Memarnejadian A.
    Drug Deliv; 2013 Jun 15; 20(3-4):190-8. PubMed ID: 23745741
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity.
    Yin R, Zheng W, Hao F, Yang XC, Zhong BY, Li QJ.
    J Dermatol Sci; 2009 Aug 15; 55(2):116-22. PubMed ID: 19500947
    [Abstract] [Full Text] [Related]

  • 40. [Expression of the human papillomavirus type 16L/E7 fusion protein in E. coli and observation of its immunogenicity in mice].
    Tian HW, Ye ZM, Lu ZH, Jao R, Bian T, Zhao L, Ruan L.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Jun 15; 20(2):33-7. PubMed ID: 16816859
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.